Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 3Sarcoma, Ewing 2Rhabdomyosarcoma 2Osteosarcoma 2Neoplasms 2Bone Neoplasms 2Stomach Neoplasms 1Soft Tissue Neoplasms 1Neuroblastoma 1Lymphoma 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Carcinosarcoma 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Ibandronic Acid 8Gemcitabine 8Doxorubicin 6Cyclophosphamide 6Zoledronic Acid 5Radiation 4Nivolumab 4Irinotecan 4pembrolizumab 3Vincristine 3Temozolomide 3Magnetic Resonance Spectroscopy 3Ipilimumab 3Docetaxel 3Denosumab 3Cisplatin 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3regorafenib 2pegfilgrastim 2Tranexamic Acid 2Trabectedin 2Surveys and Questionnaires 2Sunitinib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiosurgery 2Quality of Life 2Proton Therapy 2Observation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Neoplasms × Indocyanine Green × Sarcoma × Clear all
NCT06979115 2025-05-18

ICG-BST

Guangdong Provincial People's Hospital

Not yet recruiting
40 enrolled
Sarcoma

Bone Neoplasms, Soft Tissue Neoplasms

NCT05075889 2024-05-14

Utility of ICG in Benign Bone Tumors

Dartmouth-Hitchcock Medical Center

Phase EARLY_PHASE1 Completed
2 enrolled
Sarcoma

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡